These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 17202178)
1. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases. Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178 [TBL] [Abstract][Full Text] [Related]
2. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of antimalarial drugs in systemic lupus erythematosus. Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401 [TBL] [Abstract][Full Text] [Related]
4. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)]. Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172 [TBL] [Abstract][Full Text] [Related]
6. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258 [TBL] [Abstract][Full Text] [Related]
7. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study. Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050 [TBL] [Abstract][Full Text] [Related]
8. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB Retina; 2008; 28(10):1478-86. PubMed ID: 18997610 [TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. Parke A; West B J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146 [TBL] [Abstract][Full Text] [Related]
10. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Wolfe F; Marmor MF Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788 [TBL] [Abstract][Full Text] [Related]
11. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients]. Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616 [TBL] [Abstract][Full Text] [Related]
12. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970 [TBL] [Abstract][Full Text] [Related]
13. [Prograde conduction of the pathway in pre-excitation syndrome may shorten PJ interval]. Liu RG; Xu ZL; Zhang YJ; Sun K; Wang GP; Chen Q; Guo F; Lu Z Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1547-9. PubMed ID: 18956637 [TBL] [Abstract][Full Text] [Related]
14. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in lupus pregnancy. Clowse ME; Magder L; Witter F; Petri M Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810 [TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of antimalarial drugs in rheumatic diseases. Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568 [TBL] [Abstract][Full Text] [Related]